TerminatedNCT01913327
Antipsychotic Effects on Brain Function in Schizophrenia
Medication studyAges 18–40United States
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 40 years. Other eligibility criteria apply.
- Listed locations
- San FranciscoSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateApril 2013
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 4
- Sponsor
- University of California, San Francisco
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 40 Years
- Official registry ID
- NCT01913327
- Official title
Show the full official title
Locus Coeruleus Neuroimaging of Antipsychotic/Modafinil Interactions on Cognition in Schizophrenia
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Francisco
Questions about this study
Who is behind this study?
The study sponsor is University of California, San Francisco, a university.
Does this study involve medication?
Yes. The study involves medication, including Aripiprazole, Risperidone and Modafinil.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 40 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
